and 2014, compared with 25.1% (89 of 354) and 39.5% (879 of 2225) for general payments, respectively. Receipt of research payments was associated with increased prescribing for mRCC but not CML. Similarly, when treating payments as a continuous variable, increasing amounts of general payments were associated with increased prescribing.
No takes yet. Share an insight, caveat, or question.
Windover et al. (2018) studied this question.
Synapse has enriched 2 closely related papers on similar clinical questions. Consider them for comparative context: